Trial Profile
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 20 Jun 2012 Actual patient number is 30 according to ClinicalTrials.gov.
- 20 Jun 2012 Actual initiation date (Oct 2009) added as reported by ClinicalTrials.gov.
- 20 Jun 2012 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.